Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real‐world setting

In the present multicentre, open‐label, prospective, phase III study, we evaluated the real‐world effectiveness and ease of use of nasal glucagon (NG) in the treatment of moderate/severe hypoglycaemic events (HEs) in adults with type 1 diabetes (T1D). Patients and caregivers were taught how to use N...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Obes Metab
Main Authors: Seaquist, Elizabeth R., Dulude, Hélène, Zhang, Xiaotian M., Rabasa‐Lhoret, Remi, Tsoukas, George M., Conway, James R., Weisnagel, Stanley J., Gerety, Gregg, Woo, Vincent C., Zhang, Shuyu, Carballo, Dolorès, Pradhan, Sheetal, Piché, Claude A., Guzman, Cristina B.
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2018
Assuntos:
Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5947579/
https://ncbi.nlm.nih.gov/pubmed/29504662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13278
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados